Replies to post #228901 on Biotech Values

[DewDiligence]

TMO acquires QGEN for €39/sh in cash—a 23% premium to yesterday’s close:

http://thermofisher.mediaroom.com/2020-03-03-Thermo-Fisher-Scientific-to-Acquire-QIAGEN-N-V,1

The nominal deal value is $11.5B, including assumption of debt.

TMO seems willing to acquire almost any company in the life-sciences industry. It may be a bit too much like Valeant and Tyco for my taste. (No position.)